| (2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylicacid |
(2S,4R)-1-((S)-2-((叔丁氧基羰基)氨基)-3,3-二甲基丁酰基)-4-羟基吡咯烷-2-甲酸 |
630421-46-4 |
| N-Boc-PEG4-bromide |
N-Boc-PEG4-bromide |
1392499-32-9 |
| (S)-Methyl 2-(methylamino)propanoate hydrochloride |
(S)-2-(甲基氨基)丙酸甲酯盐酸盐 |
20045-77-6 |
| Tenalisib |
RP6530 |
1639417-53-0 |
| L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester |
索非布韦中间体 |
1256490-52-4 |
| Cbz-N-amido-PEG8-acid |
CBZ-N-AMIDO-PEG8-COOH |
1334177-87-5 |
| 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL |
4-氨基四氢-2H-吡喃-4-羧酸盐酸盐 |
217299-03-1 |
| Hydroxy-PEG1-CH2CO2tBu |
乙酸叔丁酯-乙二醇 |
287174-32-7 |
| Adenosine, 5'-aMino-5'-deoxy-2',3'-O-(1-Methylethylidene)- |
5'-氨基-5'-脱氧-2',3'-O-异丙叉腺苷 |
21950-36-7 |
| Danirixin |
GSK1325756 |
954126-98-8 |
| GSK591 |
GSK591 (EPZ-015866) |
1616391-87-7 |
| JH-II-127 |
JH-II-127 |
1700693-08-8 |
| XMD17 109 |
XMD17 109 |
1435488-37-1 |
| pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
| MC-MMAF |
MC-MMAF |
863971-19-1 |
| L-Homocyclohexyl alanine |
L-环己基丁氨酸 |
116622-38-9 |
| IDO-IN-1 |
4-氨基-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
914638-30-5 |
| Elbasvir |
艾尔巴韦 |
1370468-36-2 |
| LOXO-101 |
拉罗替尼 |
1223403-58-4 |
| Enasidenib |
恩西地平 |
1446502-11-9 |
QQ
微信
